Zhuoxin Yu

960 total citations
20 papers, 746 citations indexed

About

Zhuoxin Yu is a scholar working on Biotechnology, Molecular Biology and Biomaterials. According to data from OpenAlex, Zhuoxin Yu has authored 20 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biotechnology, 6 papers in Molecular Biology and 6 papers in Biomaterials. Recurrent topics in Zhuoxin Yu's work include Enzyme Production and Characterization (7 papers), Collagen: Extraction and Characterization (6 papers) and Diabetes Treatment and Management (4 papers). Zhuoxin Yu is often cited by papers focused on Enzyme Production and Characterization (7 papers), Collagen: Extraction and Characterization (6 papers) and Diabetes Treatment and Management (4 papers). Zhuoxin Yu collaborates with scholars based in United States, Italy and Mexico. Zhuoxin Yu's co-authors include Barbara Brodsky, Masayori Inouye, John A. M. Ramshaw, Ayumi Yoshizumi, Bo An, Oleg Mirochnitchenko, David A. Cox, Enzo Bonora, Juan P. Frías and Raleigh Malik and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Zhuoxin Yu

20 papers receiving 732 citations

Peers

Countries citing papers authored by Zhuoxin Yu

Since Specialization

Citations

This map shows the geographic impact of Zhuoxin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuoxin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuoxin Yu more than expected).

Fields of papers citing papers by Zhuoxin Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuoxin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuoxin Yu. The network helps show where Zhuoxin Yu may publish in the future.

Co-authorship network of co-authors of Zhuoxin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuoxin Yu. A scholar is included among the top collaborators of Zhuoxin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuoxin Yu. Zhuoxin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Subcutaneous (SC) nivolumab (NIVO) vs intravenous (IV) NIVO in patients with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC): Safety and patient-reported outcomes (PROs) of the randomized phase 3 CheckMate 67T trial. 2024 ·Journal of Clinical Oncology ·María T. Bourlon, Laurence Albigès, Matías Chacón, (unknown), José Maurício Mota, (unknown), Mauricio Burotto, Murilo Luz, J. Menezes, (unknown), Marco Maruzzo, Sergio Bracarda, (unknown), Zhuoxin Yu, (unknown), Matthew Dixon, Saby George	2
2	Subcutaneous nivolumab (NIVO SC) vs intravenous nivolumab (NIVO IV) in patients with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC): Pharmacokinetics (PK), efficacy, and safety results from CheckMate 67T. 2024 ·Journal of Clinical Oncology ·Saby George, María T. Bourlon, Matías Chacón, (unknown), Yamil Alonso Lopez Chuken, Bogdan Żurawski, José Maurício Mota, (unknown), Mauricio Burotto, Murilo Luz, (unknown), (unknown), Marco Maruzzo, Sergio Bracarda, (unknown), (unknown), Heather Vezina, Zhuoxin Yu, Yue Zhao, Laurence Albigès	3
3	A day‐ahead bidding strategy for battery swapping and charging system participating in the regulation market 2022 ·IET Generation Transmission & Distribution ·(unknown), S. Hou, Baikui Li, Zhuoxin Yu	5
4	Subcutaneous nivolumab versus intravenous nivolumab in patients with previously treated, advanced, or metastatic clear cell renal cell carcinoma. 2022 ·Journal of Clinical Oncology ·Matías Chacón, (unknown), Sergio Bracarda, Marco Maruzzo, María T. Bourlon, Carmel Jacobs, Begoña Pérez‐Valderrama, (unknown), Martin Eduardo Richardet, (unknown), Simon Fu, (unknown), (unknown), Zhuoxin Yu, Heather Vezina, Saby George, Laurence Albigès	2
5	Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11) 2021 ·Diabetes Care ·Juan P. Frías, Enzo Bonora, Luis Nevárez Ruiz, Ying G. Li, Zhuoxin Yu, Zvonko Miličević, Raleigh Malik, M. Angelyn Bethel, David A. Cox	123
6	Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD ‐11 2021 ·Diabetes Obesity and Metabolism ·Enzo Bonora, Juan P. Frías, Francisco J. Tinahones, Joanna Van, Raleigh Malik, Zhuoxin Yu, Reema Mody, Angelyn Bethel, Anita Y. M. Kwan, David A. Cox	41
7	357-OR: Efficacy and Safety of Dulaglutide 3mg and 4.5mg vs. Dulaglutide 1.5mg: 52-Week Results from AWARD-11 2020 ·Diabetes ·Juan P. Frías, Enzo Bonora, (unknown), Grace Li, Zhuoxin Yu, Zvonko Miličević, Raleigh Malik, Angelyn Bethel, David R. Cox	5
8	OR26-08 Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11) 2020 ·Journal of the Endocrine Society ·Juan P. Frías, Luis Nevárez Ruiz, (unknown), Zhuoxin Yu, Zvonko Miličević, Brad Woodward, David A. Cox	1
9	N-of-1 Design and Its Applications to Personalized Treatment Studies 2016 ·Statistics in Biosciences ·(unknown), Zhuoxin Yu	7
10	Bacterial collagen-like proteins that form triple-helical structures 2014 ·Journal of Structural Biology ·Zhuoxin Yu, Bo An, John A. M. Ramshaw, Barbara Brodsky	114
11	Ultrasound-guided adductor canal block for arthroscopic medial meniscectomy: a randomized, double-blind trial 2013 ·Canadian Journal of Anesthesia/Journal canadien d anesthésie ·Neil A. Hanson, Ryan Derby, David B. Auyong, Francis V. Salinas, (unknown), (unknown), Zhuoxin Yu, April Slee	58
12	Defining Requirements for Collagenase Cleavage in Collagen Type III Using a Bacterial Collagen System 2012 ·Journal of Biological Chemistry ·Zhuoxin Yu, Robert Visse, Masayori Inouye, Hideaki Nagase, Barbara Brodsky	64
13	Designed Coiled Coils Promote Folding of a Recombinant Bacterial Collagen 2011 ·Journal of Biological Chemistry ·Ayumi Yoshizumi, Jordan M. Fletcher, Zhuoxin Yu, Anton V. Persikov, Gail J. Bartlett, Aimee L. Boyle, Thomas L. Vincent, Derek N. Woolfson, Barbara Brodsky	30
14	Dissecting a Bacterial Collagen Domain from Streptococcus pyogenes 2011 ·Journal of Biological Chemistry ·Zhuoxin Yu, Barbara Brodsky, Masayori Inouye	32
15	Investigation of Collagen Glycine Substitution Mutations Leading to Disease in a Bacteria Collagen System and Collagen Like Peptides 2010 ·Biophysical Journal ·(unknown), (unknown), Zhuoxin Yu, Ayumi Yoshizumi, Barbara Brodsky	1
16	Location of Glycine Mutations within a Bacterial Collagen Protein Affects Degree of Disruption of Triple-helix Folding and Conformation 2010 ·Journal of Biological Chemistry ·Haiming Cheng, (unknown), Zhuoxin Yu, Ayumi Yoshizumi, (unknown), Barbara Brodsky	27
17	A Streptococcus pyogenes derived collagen-like protein as a non-cytotoxic and non-immunogenic cross-linkable biomaterial 2010 ·Biomaterials ·Yong Y. Peng, Ayumi Yoshizumi, Stephen J. Danon, Veronica Glattauer, (unknown), Oleg Mirochnitchenko, Zhuoxin Yu, Masayori Inouye, Jerome A. Werkmeister, Barbara Brodsky, John A. M. Ramshaw	78
18	Noncollagenous region of the streptococcal collagen‐like protein is a trimerization domain that supports refolding of adjacent homologous and heterologous collagenous domains 2010 ·Protein Science ·Zhuoxin Yu, Oleg Mirochnitchenko, Chunying Xu, Ayumi Yoshizumi, Barbara Brodsky, Masayori Inouye	21
19	Self‐association of streptococcus pyogenes collagen‐like constructs into higher order structures 2009 ·Protein Science ·Ayumi Yoshizumi, Zhuoxin Yu, Teresita Silva, Geetha Thiagarajan, John A. M. Ramshaw, Masayori Inouye, Barbara Brodsky	80
20	Expanding the Family of Collagen Proteins: Recombinant Bacterial Collagens of Varying Composition Form Triple-Helices of Similar Stability 2009 ·Biomacromolecules ·Chunying Xu, Zhuoxin Yu, Masayori Inouye, Barbara Brodsky, Oleg Mirochnitchenko	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact